Kamada Ltd. (TLV:KMDA)
Israel · Delayed Price · Currency is ILS · Price in ILA 2,260.00
-15.00 (-0.66%)
May 19, 2026, 5:29 PM IDT
Kamada Market Cap
Kamada has a market cap or net worth of 1.31 billion as of May 19, 2026. Its market cap has decreased by -4.27% in one year.
Market Cap
1.31B
Enterprise Value
1.12B
Revenue
573.62M
Ranking
n/a
PE Ratio
20.63
Stock Price
2,260.00
Market Cap Chart
Since September 12, 2005, Kamada's market cap has increased from 84.35M to 1.31B, an increase of 1,455.83%. That is a compound annual growth rate of 14.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 1.31B | 0.67% |
| Dec 31, 2025 | 1.30B | 2.55% |
| Dec 31, 2024 | 1.27B | -0.69% |
| Dec 31, 2023 | 1.28B | 108.12% |
| Dec 29, 2022 | 615.02M | -33.18% |
| Dec 30, 2021 | 920.36M | -0.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.55B |
| InterCure | 132.44M |
| Rekah Pharmaceutical Industry | 125.79M |
| Seach Medical Group | 79.19M |
| Together Pharma | 45.61M |
| Tikun Olam-Cannbit Pharmaceuticals | 13.68M |
| Nextage Therapeutics | 12.16M |
| PsyRX CNS Bio-Tech | 11.63M |